<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">IJCM</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Clinical Microbiology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2690-4721</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">IJCM-26-6132</article-id>
      <article-id pub-id-type="doi">10.14302/issn.2690-4721.ijcm-26-6132</article-id>
      <article-categories>
        <subj-group>
          <subject>case-report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Isolation of <italic>Burkholderia cepacia</italic> Complex from Pericardial Fluid in a Patient with Lung Adenocarcinoma with Metastasis: A Rare Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mirlekar</surname>
            <given-names>K</given-names>
          </name>
          <xref ref-type="aff" rid="idm1841498564">1</xref>
          <xref ref-type="aff" rid="idm1841499716">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saraf</surname>
            <given-names>M</given-names>
          </name>
          <xref ref-type="aff" rid="idm1841498564">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sarage</surname>
            <given-names>A</given-names>
          </name>
          <xref ref-type="aff" rid="idm1841498564">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1841498564">
        <label>1</label>
        <addr-line>LMMF’s Mai Mangeshkar Hospital</addr-line>
      </aff>
      <aff id="idm1841499716">
        <label>*</label>
        <addr-line>Corresponding Author </addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>N.</surname>
            <given-names>R. Rajagopalan</given-names>
          </name>
          <xref ref-type="aff" rid="idm1841345132">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1841345132">
        <label>1</label>
        <addr-line>Assistant Professor, Department of Chemistry, St. Joseph’s College of Engineering, Chennai </addr-line>
      </aff>
      <author-notes>
        <corresp>
    
    Mirlekar K, <addr-line>LMMF’s Mai Mangeshkar Hospital</addr-line>, <email>komal.mirlekar@gmail.com</email></corresp>
        <fn fn-type="conflict" id="idm1842658948">
          <p>The authors have no conflict of interest to declare.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2026-07-28">
        <day>28</day>
        <month>07</month>
        <year>2026</year>
      </pub-date>
      <volume>1</volume>
      <issue>4</issue>
      <fpage>8</fpage>
      <lpage>12</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>03</month>
          <year>2026</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>04</month>
          <year>2026</year>
        </date>
        <date date-type="online">
          <day>28</day>
          <month>07</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©</copyright-statement>
        <copyright-year>2026</copyright-year>
        <copyright-holder>Mirlekar K, et al.</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/ijcm/article/2379">This article is available from http://openaccesspub.org/ijcm/article/2379</self-uri>
      <abstract>
        <p><italic>Burkholderia cepacia</italic> complex was isolated from pericardial fluid in a patient with metastatic lung adenocarcinoma, representing a rare opportunistic pericardial infection. Clinical improvement following targeted antimicrobial therapy supported its pathogenic significance and highlights the importance of microbiological evaluation of malignant pericardial effusions. </p>
      </abstract>
      <kwd-group>
        <kwd>Burkholderia cepacia complex</kwd>
        <kwd>pericardial fluid infection</kwd>
        <kwd>lung adenocarcinoma metastasis</kwd>
        <kwd>opportunistic infection</kwd>
        <kwd>malignant pericardial effusion</kwd>
      </kwd-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="0"/>
        <page-count count="5"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1841341244" sec-type="intro">
      <title>Introduction</title>
      <p>The <italic>Burkholderia cepacia</italic> complex comprises environmental non-fermenting Gram-negative bacilli associated with opportunistic infections in immunocompromised hosts <xref ref-type="bibr" rid="ridm1841922612">1</xref><xref ref-type="bibr" rid="ridm1841917716">2</xref><xref ref-type="bibr" rid="ridm1841747812">12</xref>. Pericardial involvement is extremely rare <xref ref-type="bibr" rid="ridm1841929316">3</xref>. In tuberculosis-endemic regions, malignant and infectious effusions pose significant diagnostic challenges <xref ref-type="bibr" rid="ridm1842020484">4</xref><xref ref-type="bibr" rid="ridm1841741012">13</xref>. We report an unusual case of <italic>Burkholderia cepacia</italic> complex isolated from pericardial fluid in a patient with lung adenocarcinoma with metastasis.</p>
    </sec>
    <sec id="idm1841341820" sec-type="cases">
      <title>Case Presentation</title>
      <p>A 50-year-old female from Moregaon presented with dry cough for two months, fever for one month, and Grade III dyspnoea for three weeks. She had a 25-year history of tobacco (misri) use and occupational exposure to smoke from burning agricultural leaves.</p>
      <p>On admission, the patient had cough, cold, body ache, and Grade III             dyspnoea requiring oxygen support. Physical examination revealed             bilateral crepitations.</p>
      <sec id="idm1841341388">
        <title>Investigations</title>
        <p>CT chest demonstrated right-sided pleural effusion, lung atelectasis, mild cardiomegaly, and pericardial effusion.</p>
        <p>2D echocardiography showed:</p>
        <p>· Normal cardiac chambers</p>
        <p>· LVEF 60%</p>
        <p>· Mild TR and MR</p>
        <p>· Mild-to-moderate pericardial effusion (maximum thickness 2 cm)</p>
        <p>· No vegetations or thrombus</p>
      </sec>
      <sec id="idm1841340308">
        <title>Serology</title>
        <p>· HIV negative</p>
        <p>· HCV negative</p>
        <p>· HBsAg positive</p>
        <p>· HBV DNA viral load &gt;4000 IU/ml</p>
      </sec>
      <sec id="idm1841347796">
        <title>Tuberculosis Workup</title>
        <p>· ZN stain: negative</p>
        <p>· GeneXpert: negative</p>
        <p>· ADA: 7.5 U/L</p>
      </sec>
      <sec id="idm1841347724">
        <title>Fluid Analysis</title>
        <p>· USG-guided pleural tapping: 750 ml</p>
        <p>· Pericardial tapping: 300 ml</p>
      </sec>
      <sec id="idm1841345636">
        <title>Cytology and Immunohistochemistry</title>
        <p>Pleural fluid cytology revealed Category V malignant cells (IACGRSE 2020).</p>
        <p>Cytology slides studied from pericardial fluid showed atypical cells with high N: C ratio are arranged in 3 dimensional balls and glandular pattern. Slides were positive for malignant cells. Confirmation is done by IHC</p>
        <fig id="idm1841564900">
          <graphic xlink:href="images/image1.jpg" mime-subtype="jpg"/>
        </fig>
        <p>IHC findings:</p>
        <p>· TTF-1 positive</p>
        <p>· Napsin A positive</p>
        <p>· BerEP4 positive</p>
        <p>· PAX8 negative</p>
        <p>· GATA3 negative</p>
        <p>· Calretinin highlighted mesothelial cells</p>
      </sec>
      <sec id="idm1841333532">
        <title>Diagnosis</title>
        <p>Lung adenocarcinoma with metastasis.</p>
        <p>PET scan showed FDG-avid consolidative right lung mass with regional nodal involvement, multiple hepatic deposits, and multiple skeletal metastases.</p>
        <p>Cytology slides studied from pericardial fluid shows atypical cells with high N: C ratio are arranged in 3 dimensional balls and glandular pattern. Slides are positive for malignant cells. Confirmation is done by IHC</p>
      </sec>
      <sec id="idm1841333244">
        <title>Microbiology</title>
        <p>Sputum culture showed no pathogenic growth.</p>
        <p>Pleural fluid cultures demonstrated no microbial growth.</p>
        <p>Pericardial fluid culture yielded <italic>Burkholderia cepacia</italic> complex on Vitek 2. Antimicrobial susceptibility testing was interpreted cautiously, as Clinical and Laboratory Standards Institute (CLSI) 2025 guidelines do not routinely recommend reporting susceptibility for certain antimicrobial agents against this organism <xref ref-type="bibr" rid="ridm1841774092">5</xref><xref ref-type="bibr" rid="ridm1841750692">11</xref>. However, testing was performed upon clinician request using CLSI 2024 interpretative criteria <xref ref-type="bibr" rid="ridm1841775604">6</xref> to guide therapy <xref ref-type="bibr" rid="ridm1841750692">11</xref>.</p>
        <p>The isolate demonstrated:</p>
        <p>· Sensitive: trimethoprim–sulfamethoxazole, levofloxacin, meropenem</p>
        <p>· Intermediate: minocycline</p>
        <p>· Resistant: ceftazidime</p>
        <p>The possibility of laboratory contamination was carefully evaluated. The organism was isolated from a normally sterile site obtained via aseptic ultrasound-guided pericardiocentesis. Correlation with clinical findings and subsequent symptomatic improvement following targeted antimicrobial therapy supported its clinical significance rather than incidental contamination.</p>
        <p>Pleural fluid cultures remained sterile, suggesting localized pericardial infection rather than disseminated pleuro-pericardial involvement. Isolation of an organism from a sterile body site along with compatible clinical presentation, exclusion of alternative etiologies, and therapeutic response fulfills accepted microbiological criteria for designation as a true pathogen.</p>
      </sec>
      <sec id="idm1841337852">
        <title>Treatment</title>
        <p>The patient received:</p>
        <p>· Meropenem</p>
        <p>· Teicoplanin</p>
        <p>Chemotherapy was initiated with:</p>
        <p>· Pemetrexed</p>
        <p>· Carboplatin</p>
        <p>· Granisetron</p>
        <p>· Supportive therapy</p>
        <p>Following initiation of targeted antimicrobial therapy, the patient showed gradual symptomatic                improvement, including reduction in dyspnoea and improved overall clinical status. Oxygen requirement decreased progressively during hospitalization.</p>
      </sec>
    </sec>
    <sec id="idm1841338068" sec-type="discussion">
      <title>Discussion</title>
      <p><italic>Burkholderia cepacia</italic> complex is an opportunistic non-fermenting Gram-negative bacillus known for intrinsic antimicrobial resistance and survival in moist environmental and healthcare settings <xref ref-type="bibr" rid="ridm1841922612">1</xref><xref ref-type="bibr" rid="ridm1841917716">2</xref><xref ref-type="bibr" rid="ridm1841771284">7</xref><xref ref-type="bibr" rid="ridm1841747812">12</xref>. Infection predominantly occurs in immunocompromised hosts.</p>
      <p>In this case, two states were present. The primary factor was lung adenocarcinoma with metastasis, associated with impaired cellular immunity and malignant effusion formation. The second factor was chronic hepatitis B infection, which may further impair immune responses through chronic inflammation and immune dysregulation <xref ref-type="bibr" rid="ridm1841764980">8</xref><xref ref-type="bibr" rid="ridm1841736044">15</xref>. The coexistence of these conditions likely predisposed the patient to opportunistic infection.</p>
      <p>A key clinical question remains how BCC entered the pericardial space in the absence of cardiac surgery or invasive procedures. Possible mechanisms include hematogenous dissemination from transient bacteremia or contiguous spread from adjacent pulmonary pathology. Agricultural environmental exposure may also have contributed to colonization followed by opportunistic invasion.</p>
      <p>An important diagnostic challenge was distinguishing true infection from contamination. Although BCC can exist as an environmental organism, several findings supported pathogenicity in this case:</p>
      <p>· Isolation from a sterile anatomical site</p>
      <p>· Compatible clinical illness</p>
      <p>· Exclusion of tuberculosis and other pathogens</p>
      <p>· Sterile pleural fluid cultures</p>
      <p>· Clinical improvement after targeted antimicrobial therapy</p>
      <p>Together, these factors strongly support true infection rather than laboratory contamination.</p>
      <p>Malignant effusions are typically sterile unless secondary infection develops <xref ref-type="bibr" rid="ridm1841760516">9</xref><xref ref-type="bibr" rid="ridm1841741012">13</xref>. This case highlights the importance of routine microbiological analysis even when malignancy is confirmed. Early identification enabled targeted therapy guided by susceptibility testing performed under clinician request using CLSI 2024 criteria <xref ref-type="bibr" rid="ridm1841775604">6</xref>.</p>
      <p>Tubercular pericarditis was excluded through negative molecular testing and low ADA levels, an essential consideration in endemic regions <xref ref-type="bibr" rid="ridm1842020484">4</xref><xref ref-type="bibr" rid="ridm1841758644">10</xref>.</p>
    </sec>
    <sec id="idm1841336556" sec-type="conclusions">
      <title>Conclusions</title>
      <p><italic>Burkholderia cepacia</italic> complex may rarely infect the pericardial space in patients with lung adenocarcinoma with metastasis, particularly in the presence of chronic hepatitis B infection. Although malignant pericardial effusions are generally considered sterile, secondary opportunistic infections should be suspected when clinical symptoms persist.</p>
      <p>The absence of prior cardiac intervention raises important questions regarding pathogenesis and suggests possible hematogenous or contiguous spread in susceptible hosts. Clinical improvement following targeted antimicrobial therapy further supports the organism’s pathogenic role rather than contamination.</p>
      <p>Comprehensive microbiological evaluation of pericardial fluid remains essential for accurate diagnosis and management. Multidisciplinary collaboration between clinicians, microbiologists, and pathologists is crucial for optimal care. Recognition of such rare infections expands clinical understanding and supports evidence-based management of complex oncological patients.<xref ref-type="bibr" rid="ridm1841738636">14</xref></p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ridm1841922612">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Mahenthiralingam</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Baldwin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dowson</surname>
            <given-names/>
          </name>
          <article-title>CG: Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.J Appl Microbiol</article-title>
          <date>
            <year>2008</year>
          </date>
          <fpage>104</fpage>
          <lpage>1539</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841917716">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Rhodes</surname>
            <given-names>K A</given-names>
          </name>
          <article-title>Schweizer HP: Antibiotic resistance in Burkholderia species.Drug Resist Updat</article-title>
          <date>
            <year>2016</year>
          </date>
          <volume>28</volume>
          <fpage>82</fpage>
          <lpage>90</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841929316">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Cunha</surname>
            <given-names>B A</given-names>
          </name>
          <article-title>Pericardial infections: diagnostic and therapeutic considerations.Infect Dis Clin North Am</article-title>
          <date>
            <year>2017</year>
          </date>
          <volume>31</volume>
          <fpage>589</fpage>
          <lpage>601</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842020484">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Imazio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Adler</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Management of pericardial effusion.Eur</article-title>
          <date>
            <year>2013</year>
          </date>
          <volume>34</volume>
          <fpage>1186</fpage>
          <lpage>1197</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841774092">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <date>
            <year>2025</year>
          </date>
          <chapter-title>Clinical and Laboratory Standards Institute:Performance Standards for Antimicrobial Susceptibility Testing. CLSI M100. 35th ed</chapter-title>
          <publisher-loc>Wayne, PA;</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1841775604">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <date>
            <year>2024</year>
          </date>
          <chapter-title>Clinical and Laboratory Standards Institute:Performance Standards for Antimicrobial Susceptibility Testing. CLSI M100. 34th ed</chapter-title>
          <publisher-loc>Wayne, PA;</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1841771284">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Sousa</surname>
            <given-names>S A</given-names>
          </name>
          <name>
            <surname>Ramos</surname>
            <given-names>C G</given-names>
          </name>
          <article-title>Leitão JH: Burkholderia cepacia complex: emerging multihost pathogens equipped with virulence factors.Int J Mol Sci</article-title>
          <date>
            <year>2011</year>
          </date>
          <volume>12</volume>
          <fpage>6609</fpage>
          <lpage>6633</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841764980">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Rehermann</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nascimbeni</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Immunology of hepatitis B virus infection.Nat Rev Immunol</article-title>
          <date>
            <year>2005</year>
          </date>
          <volume>5</volume>
          <fpage>215</fpage>
          <lpage>229</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841760516">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Maisch</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Seferović</surname>
            <given-names>P M</given-names>
          </name>
          <name>
            <surname>Ristić</surname>
            <given-names>A D</given-names>
          </name>
          <article-title>Guidelines on diagnosis and management of pericardial diseases.Eur</article-title>
          <date>
            <year>2015</year>
          </date>
          <volume>36</volume>
          <fpage>2921</fpage>
          <lpage>2964</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841758644">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Mayosi</surname>
            <given-names>B M</given-names>
          </name>
          <name>
            <surname>Burgess</surname>
            <given-names>L J</given-names>
          </name>
          <article-title>Doubell AF: Tuberculous pericarditis.Circulation</article-title>
          <date>
            <year>2005</year>
          </date>
          <fpage>112</fpage>
          <lpage>3608</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841750692">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <date>
            <year>2025</year>
          </date>
          <chapter-title>Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. 36th ed</chapter-title>
          <publisher-loc>Wayne, PA;</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1841747812">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>JEA</surname>
            <given-names>Zlosnik</given-names>
          </name>
          <name>
            <surname>Costa</surname>
            <given-names>P S</given-names>
          </name>
          <name>
            <surname>Brant</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Burkholderia cepacia complex infections in immunocompromised hosts: updated epidemiology and therapeutic challenges. Clin Microbiol Rev</article-title>
          <date>
            <year>2024</year>
          </date>
          <fpage>37</fpage>
          <lpage>00214</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841741012">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Imazio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gaita</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>LeWinter</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Contemporary management of pericardial diseases: advances in diagnosis and therapy. Eur Heart</article-title>
          <date>
            <year>2024</year>
          </date>
          <volume>45</volume>
          <fpage>1123</fpage>
          <lpage>1138</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841738636">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Gupta</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Non-fermenting Gram-negative bacilli as emerging pathogens in oncology patients: a 5-year tertiary care study. J Infect Public Health</article-title>
          <date>
            <year>2024</year>
          </date>
          <volume>17</volume>
          <fpage>102345</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841736044">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Health</surname>
            <given-names>World</given-names>
          </name>
          <article-title>Organization: Global hepatitis report 2025: hepatitis B epidemiology and immune implications</article-title>
          <date>
            <year>2025</year>
          </date>
          <publisher-name>WHO Press</publisher-name>
          <publisher-loc>Geneva;</publisher-loc>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
